Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus

Mathematical Biosciences

Volumn 270, Issue , 2015, Pages 169-182

  Jacobsen, Karly ^a,b   Pilyugin, Sergei S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Free boundary problem; Hyperbolic parabolic system; Oncolytic virus; Syncytia; Tumor

Indexed keywords

CELL DEATH; CELLS; CYTOLOGY; DIFFERENTIAL EQUATIONS; ONCOGENIC VIRUSES; ONCOLOGY; VIRUSES;

EXISTENCE AND UNIQUENESS; FREE-BOUNDARY PROBLEMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUS; PARABOLIC SYSTEM; PARTIAL DIFFERENTIAL; SPATIALLY HOMOGENEOUS; SYNCYTIA;

TUMORS;

FUSOGENIC ONCOLYTIC VIRUS; ONCOLYTIC HERPES VIRUS; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

CANCER; COMPUTER SIMULATION; DISEASE TREATMENT; NUMERICAL MODEL; PUBLIC HEALTH; TUMOR;

ARTICLE; GLIOMA; HERPES SIMPLEX VIRUS 1; MATHEMATICAL MODEL; ONCOLYTIC VIROTHERAPY; SIMULATION; TUMOR GROWTH; VIRUS ENTRY; VIRUS RELEASE; HUMAN; NEOPLASMS; THEORETICAL MODEL;

HUMANS; MODELS, THEORETICAL; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES;

EID: 84949537249     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2015.02.009     Document Type: Article

References (28)

1. Parato K., Senger D., Forsyth P., Bell J. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 2005, 5(12):965-976. 10.1038/nrc1750.
2. Ebert O., Shinozaki K., Kournioti C., Park M., García-Sastre A., Woo S. Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. Cancer Res. 2004, 64(9):3265.
3. Kelly E., Russell S. History of oncolytic viruses: genesis to genetic engineering. Mol. Ther. 2007, 15(4):651-659.
4. Bateman A., Harrington K., Kottke T., Ahmed A., Melcher A., Gough M., Linardakis E., Riddle D., Dietz A., Lohse C., et al. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res. 2002, 62(22):6566.
5. Bateman A., Bullough F., Murphy S., Emiliusen L., Lavillette D., Cosset F., Cattaneo R., Russell S., Vile R. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 2000, 60(6):1492.
6. Fu X., Zhang X. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Cancer Res. 2002, 62(8):2306.
7. McDonald C., Erlichman C., Ingle J., Rosales G., Allen C., Greiner S., Harvey M., Zollman P., Russell S., Galanis E. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Res. Treat. 2006, 99(2):177-184. 10.1007/s10549-006-9200-5.
8. Lin E.H., Salon C., Brambilla E., Lavillette D., Szecsi J., Cosset F.L., Coll J.L. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer. Cancer Gene Ther. 2010, 17(4):256-265. 10.1038/cgt.2009.74.
9. Nakamori M., Fu X., Rousseau R., Chen S., Zhang X. Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity. Mol. Ther. 2004, 9(5):658-665. 10.1016/j.ymthe.2004.02.019.
10. Wu J., Byrne H., Kirn D., Wein L. Modeling and analysis of a virus that replicates selectively in tumor cells. Bull. Math. Biol. 2001, 63(4):731-768.
11. Wu J.T., Kirn D.H., Wein L.M. Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response. Bull. Math. Biol. 2003, 66(4):605-625. 10.1016/j.bulm.2003.08.016.
12. Wein L., Wu J., Kirn D. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res. 2003, 63(6):1317-1324.
13. Friedman A., Tao Y. Analysis of a model of a virus that replicates selectively in tumor cells. J. Math. Biol. 2003, 47(5):391-423.
14. Tao Y., Guo Q. The competitive dynamics between tumor cells, a replication-competent virus and an immune response. J. Math. Biol. 2005, 51(1):37-74. 10.1007/s00285-004-0310-6.
15. Wang J., Tian J. Numerical study for a model of tumor virotherapy. Appl. Math. Comput. 2008, 196(1):448-457.
16. Bajzer Ž., Carr T., Josić K., Russell S., Dingli D. Modeling of cancer virotherapy with recombinant measles viruses. J. Theor. Biol. 2008, 252(1):109-122.
17. Dingli D., Offord C., Myers R., Peng K., Carr T.W., Josic K., Russell S., Bajzer Z. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Ther. 2009, 16(12):873-882.
18. Biesecker M., Kimn J., Lu H., Dingli D., Bajzer Ž. Optimization of virotherapy for cancer. Bull. Math. Biol. 2010, 72(2):469-489.
19. Reis C., Pacheco J., Ennis M., Dingli D. In silico evolutionary dynamics of tumour virotherapy. Integr. Biol. 2010, 2(1):41-45. 10.1039/b917597k.
20. Landau H. Heat conduction in a melting solid. Quart. Appl. Math 1950, 8(1):81-94.
21. Chicone C. Ordinary Differential Equations with Applications 2006, 34. Springer. 2nd.
22. Friedman A. Partial Differential Equations of Parabolic Type 1964, 196. Prentice-Hall, Englewood Cliffs, NJ.
23. Leung A. Systems of Nonlinear Partial Differential Equations: Applications to Biology and Engineering 1989, Kluwer Academic Publishers Boston.
24. Friedman A., Tian J., Fulci G., Chiocca E., Wang J. Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res. 2006, 66(4):2314.
25. Fulci G., Breymann L., Gianni D., Kurozomi K., Rhee S., Yu J., Kaur B., Louis D., Weissleder R., Caligiuri M., et al. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc. Nat. Acad. Sci. 2006, 103(34):12873-12878.
26. Kurozumi K., Hardcastle J., Thakur R., Shroll J., Nowicki M., Otsuki A., Chiocca E.A., Kaur B. Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates cyr61. Mol. Ther. 2008, 16(8):1382-1391.
27. Nii S., Morgan C., Rose H.M. Electron microscopy of herpes simplex virus: Ii. sequence of development. J. Virol. 1968, 2(5):517.
28. Thomas L. Elliptic problems in linear difference equations over a network. Watson Sci. Comput. Lab. Rept., Columbia University, New York 1949.